Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Condition(s):Peripheral T-cell LymphomaLast Updated:December 19, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Peripheral T-cell LymphomaLast Updated:December 19, 2019Completed
Condition(s):Breast Cancer; Breast Tumors; Neoplasms, Breast; Cancer of the Breast; Human Mammary CarcinomaLast Updated:January 7, 2020Completed
Condition(s):Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell LymphomaLast Updated:December 18, 2019Completed
Condition(s):Ovarian Cancer; Fallopian Tube Cancer; Peritoneal CancerLast Updated:January 19, 2018Completed
Condition(s):Lymphoma, T-CellLast Updated:March 31, 2022Unknown status
Condition(s):Carcinoma, Transitional Cell; Bladder Cancer; Bladder NeoplasmLast Updated:December 17, 2019Completed
Condition(s):Relapsed or Refractory Peripheral T-cell LymphomaLast Updated:November 29, 2017Completed
Condition(s):Relapsed or Refractory Lymphoproliferative Malignancies; Hodgkin’s Lymphoma; Peripheral T-cell Lymphoma; B-cell Lymphoma; Waldenstrom’s MacroglobulinemiaLast Updated:January 7, 2020Completed
Condition(s):Adenocarcinoma of the Esophagus; Adenocarcinomas of the Gastroesophageal Junction; Recurrent Esophageal Cancer; Squamous Cell Carcinoma of the Esophagus; Stage IV Esophageal CancerLast Updated:June 1, 2016Completed
Condition(s):Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell LymphomaLast Updated:September 22, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.